{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:41:55Z","timestamp":1786653715954,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijo.ijo_314_17","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T23:34:16Z","timestamp":1510616056000},"page":"1166","source":"Crossref","is-referenced-by-count":12,"title":["Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis"],"prefix":"10.4103","volume":"65","author":[{"given":"Sarita","family":"Beri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Shandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.218040-1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjo.29.2.57","article-title":"Penicillin and the control of deep intra-ocular infection","author":"Rycroft","year":"1945","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":", Meyerle CB, Yannuzzi LA, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.218040-3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.218040-4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.11.1.57","article-title":"Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia","author":"Denton","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0301-4738.218040-5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10096-010-0882-6","article-title":"Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009","author":"Araoka","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0301-4738.218040-6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0002-9394(14)74063-2","article-title":"Xanthomonas maltophilia endophthalmitis after implantation of sustained-release ganciclovir","author":"Chen","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-7","first-page":"81","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): Results of the Pan-American Collaborative Retina Study Group (PACORES)","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/IAE.0b013e3181884fd2","article-title":"Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab","author":"Fintak","year":"2008","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.218040-9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/eye.2009.7","article-title":"Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection","author":"Artunay","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.218040-10","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.ophtha.2013.05.018","article-title":"A4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration","author":"Rasmussen","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.218040-11","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1167\/iovs.13-11993","article-title":"Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes","author":"Gillies","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218040-12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bjophthalmol-2012-302435","article-title":"Intravitreal injections at the Massachusetts Eye and Ear Infirmary: Analysis of treatment indications and postinjection endophthalmitis rates","author":"Englander","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","article-title":", Schwartz SG, Davis JL, Murray TG, et al. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: A six-year experience at a university referral center","author":"Moshfeghi","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.218040-14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1097\/IAE.0b013e318287da92","article-title":"Bimanual assisted eyelid retraction technique for intravitreal injections","author":"Fineman","year":"2013","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.218040-15","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","article-title":"Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask","author":"Shimada","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/eye.2012.199","article-title":"Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: Incidence, features, risk factors, and outcomes","author":"Lyall","year":"2012","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.218040-17","first-page":"1388","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results","author":"Comparison","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.218040-18","first-page":"1399","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial","author":"IVAN","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.218040-19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s15010-008-8150-8","article-title":"Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients","author":"Horster","year":"2009","journal-title":"Infection"},{"key":"key-10.4103\/0301-4738.218040-20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/OPTH.S39608","article-title":", Miller D, Smiddy WE.Stenotrophomonas maltophilia endophthalmitis following cataract surgery: Clinical and microbiological results","author":"Chang","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-21","first-page":"383","article-title":"Stenotrophomonas maltophilia endophthalmitis caused by surgical equipment contamination: An emerging nosocomial infection","author":"Williams","year":"2014","journal-title":"J Ophthalmic Vis Res","ISSN":"https:\/\/id.crossref.org\/issn\/2008-322X","issn-type":"print"},{"key":"key-10.4103\/0301-4738.218040-22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2415-15-14","article-title":"Post-cataract endophthalmitis caused by multidrug-resistant Stenotrophomonas maltophilia: Clinical features and risk factors","author":"Ji","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-23","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.3928\/15428877-20100910-03","article-title":"Endophthalmitis caused by Stenotrophomonas maltophilia","author":"Chen","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.218040-24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archopht.1996.01100130429013","article-title":"Stenotrophomonas maltophilia ocular infections","author":"Penland","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.218040-25","unstructured":"Kumar A. Guidelines for Intravitreal Injections; 2016. Available from: http:\/\/www.aios.org\/avguidelines.pdf. [Last accessed on 2016 Feb 08]."}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:25Z","timestamp":1786650085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_314_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"alternative-id":["218040"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_314_17","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}